cancer drugs

Oncology

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

News

China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.

News

In today's King's Speech, the UK government unveiled the NHS Modernisation Bill, starting the process of introducing a single patient record.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.